Fine Wine Investing Explained: Part 3 - The Last 20 Years

Chris looks at 22 years of Liv-ex data to see how fine wine has really performed since 2004, comparing the Liv-ex 50, 100 and 1000 against the FTSE, Dow Jones and NASDAQ, once fees and storage costs are taken into account.

Rare bottles. Bonded warehouses. Six figure sales. Chris pulls back the curtain on the fine wine collector market and how the trade really works.

Chris Scott breaks down the fine wine investment market: the three distinct markets, and why provenance and storage make or break a wine's value.

Why do some grape varieties resist mildew while others don't? Dr Darrell Lizamore breaks down the genetics of PIWI grapes and what it takes to breed disease resistance into a vine without losing flavour.

Dr Darrell Lizamore of the Bragato Research Institute explains how New Zealand scientists are breeding new clones of Sauvignon Blanc, aiming for disease resistance, frost tolerance and better flavour without losing the grape's true identity.

Dr Darrell Lizamore of New Zealand Winegrowers explains how grapevine genetics really works, from centuries of clonal selection and mass selection to induced mutation, transgenics, CRISPR gene editing and epigenetics.

Powdery mildew is getting harder to control in Marlborough. Jim White of Cloudy Bay explains why, and why a new generation of disease-resistant PIWI grape varieties might be the answer New Zealand growers have been waiting for.

Get up close and personal with Jim White as he shares his insights on Cloudy Bay Sauvignon Blanc and the region that has shaped it.

WineGB. 500 members. One CEO. Nicola Bates joins Chris to talk lobbying, duty reform, hybrid grapes and why English wine needs government support to keep growing.

How many bottles does England actually make? Where are we exporting? And can vineyards really make money? WineGB CEO Nicola Bates has the numbers - and some honest answers.